<DOC>
	<DOCNO>NCT02511535</DOCNO>
	<brief_summary>Allergic patient especially undergoing de-sensitization treatment alter immune responsiveness . The investigator aim find whether influence immune response primary booster vaccination .</brief_summary>
	<brief_title>TBE Vaccination Allergic Patients</brief_title>
	<detailed_description>Allergic patient generally alter immunologic profile ( Th2 bias ) , allergic individual undergo de-sensitization treatment display increase production immune supressive cytokine . The investigator measure humoral cellular immune response routine vaccination ( TBE booster ) allergic patient without de-sensitization treatment determine whether allergy negatively influence vaccine induce immune response protection .</detailed_description>
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>complete primary TBE immunization + least one booster immunization adult sex 18 60 year age willingness sign write informed consent form age &lt; 18 &gt; 60 year prior TBE infection Hepatitis A vaccination pregnancy breast feed acute infection day inclusion ( day 0 ) , body temperature &gt; 37,9°C concomitant medication : systemic cortisone therapy , chemotherapy , immunosuppressive therapy 4 week prior study administration vaccine 4 week before/after TBE vaccination plan surgery within 2 week before/after TBE vaccination Start desensitization first 4 week allergen dose escalation contraindication administration FSMEImmun® vaccine accord manufacturer 's instruction history malignant disease within last 5 year autoimmune disease drug addiction plasma donor receipt blood transfusion immuno globulin within 3 month study entry</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>